Drug Profile


Alternative Names: TJSL

Latest Information Update: 02 Jun 2017

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator China Aoxing Pharmaceutical
  • Developer Aoxing Pharmaceutical Company
  • Class
  • Mechanism of Action Prostaglandin inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Dysmenorrhoea

Most Recent Events

  • 02 Jun 2017 Discontinued - Preregistration for Dysmenorrhoea in China (PO), because not listed on Aoxing pipeline, June 2017
  • 07 May 2013 Preregistration for Dysmenorrhoea in China (PO)
  • 28 Sep 2011 Aoxing Pharmaceutical Company completes a phase III trial in Dysmenorrhoea in China
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top